Found: 3
Select item for more details and to access through your institution.
Prognostic Role of Clinicopathological Characteristics and Serum Markers in Metastatic Melanoma Patients Treated with BRAF and MEK Inhibitors.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2981, doi. 10.3390/cancers16172981
- By:
- Publication type:
- Article
Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors for survival in metastatic melanoma patients treated with anti-PD-1.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1237643
- By:
- Publication type:
- Article
Combining Biomarkers for the Diagnosis of Metastatic Melanoma.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 1, p. 174, doi. 10.3390/jcm13010174
- By:
- Publication type:
- Article